JBIO market overview

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.

Latest price: $14.71
Daily change: +0.00%
Market state: closed
As of: 2026-09-23 19:30:01 ET

The interactive chart loads with current market data when StockStorm starts.

Market information is provided for research and visualization and is not investment advice.